Finn Sawyer Access to Cancer Testing Act
Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · Feb 26, 2025
View full text on Congress.gov ↗ Policy area: Health
Finn Sawyer Access to Cancer Testing Act This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer. Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Source: Congressional Research Service (CRS).
Track HR 1620 in BallotBox360
Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.
Download on iOS Open Web App